Literature DB >> 19576665

Immune interference after sequential alphavirus vaccine vaccinations.

Phillip R Pittman1, Ching-Tong Liu, Timothy L Cannon, Joseph A Mangiafico, Paul H Gibbs.   

Abstract

We compared the effect of order of administration of investigational alphavirus vaccines on neutralizing antibody response. Volunteers who received the inactivated eastern and western equine encephalitis (EEE and WEE) vaccines before live attenuated Venezuelan (VEE) vaccine had significantly lower rates of antibody response than those receiving VEE vaccine before EEE and WEE vaccines (66.7% vs. 80.6%; p=0.026). The odds of having a VEE antibody non-response among those initially receiving EEE and WEE vaccines, adjusted for gender, were significant (odds ratio [OR]=2.20; 95% CI=1.2-4.1 [p=0.0145]) as were the odds of non-response among females adjusted for group (OR=1.81; 95% CI=1.2-2.7 [p=0.0037]). Antibody interference and gender effect have major implications for vaccine strategy among those receiving multiple alphavirus vaccines and those developing next generation vaccines for these threats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576665     DOI: 10.1016/j.vaccine.2009.02.090

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.

Authors:  Farooq Nasar; Demetrius Matassov; Robert L Seymour; Theresa Latham; Rodion V Gorchakov; Rebecca M Nowak; Grace Leal; Stefan Hamm; John H Eldridge; Robert B Tesh; David K Clarke; Scott C Weaver
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.

Authors:  Jesse H Erasmus; Robert L Seymour; Jason T Kaelber; Dal Y Kim; Grace Leal; Michael B Sherman; Ilya Frolov; Wah Chiu; Scott C Weaver; Farooq Nasar
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

3.  Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.

Authors:  Douglas S Reed; Pamela J Glass; Russell R Bakken; James F Barth; Cathleen M Lind; Luis da Silva; Mary Kate Hart; Jonathan Rayner; Kim Alterson; Max Custer; Jeanne Dudek; Gary Owens; Kurt I Kamrud; Michael D Parker; Jonathan Smith
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

4.  Current strategic thinking for the development of a trivalent alphavirus vaccine for human use.

Authors:  Daniel N Wolfe; D Gray Heppner; Shea N Gardner; Crystal Jaing; Lesley C Dupuy; Connie S Schmaljohn; Kevin Carlton
Journal:  Am J Trop Med Hyg       Date:  2014-05-19       Impact factor: 2.345

5.  Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): comparison of naïve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells.

Authors:  Rebecca Erwin-Cohen; Aimee Porter; Phillip Pittman; Cynthia Rossi; Luis Dasilva
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

6.  Neutralizing Antibodies from Convalescent Chikungunya Virus Patients Can Cross-Neutralize Mayaro and Una Viruses.

Authors:  Karen A Martins; Melissa K Gregory; Stephanie M Valdez; Thomas R Sprague; Liliana Encinales; Nelly Pacheco; Carlos Cure; Alexandra Porras-Ramirez; Alejandro Rico-Mendoza; Aileen Chang; Margaret L Pitt; Farooq Nasar
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

7.  Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.

Authors:  Emily E Coates; Srilatha Edupuganti; Grace L Chen; Myra Happe; Larisa Strom; Alicia Widge; Maria Burgos Florez; Josephine H Cox; Ingelise Gordon; Sarah Plummer; Abidemi Ola; Galina Yamshchikov; Charla Andrews; Sharon Curate-Ingram; Patricia Morgan; Shashi Nagar; Matthew H Collins; Amy Bray; Thuy Nguyen; Judy Stein; Christopher L Case; Florence Kaltovich; Diane Wycuff; C Jason Liang; Kevin Carlton; Sandra Vazquez; John R Mascola; Julie E Ledgerwood
Journal:  Lancet Infect Dis       Date:  2022-05-11       Impact factor: 71.421

8.  Precision immunization: a new trend in human vaccination.

Authors:  Siyue Jia; Jingxin Li; Yuanbao Liu; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

Review 9.  Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.

Authors:  Anthony Torres-Ruesta; Rhonda Sin-Ling Chee; Lisa F P Ng
Journal:  Microorganisms       Date:  2021-04-22

10.  The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.

Authors:  Ann R Hunt; Shana Frederickson; Toshiaki Maruyama; John T Roehrig; Carol D Blair
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.